CAMP4 Therapeutics Corporation (CAMP) vs Q32 Bio Inc. (QTTB)
- CAMP4 Therapeutics Corporation CAMP 3.79 −5.25%
- Q32 Bio Inc. QTTB 8.34 −1.65%
CAMP4 Therapeutics Corporation and Q32 Bio Inc. are both Biotechnology companies. CAMP4 Therapeutics Corporation and Q32 Bio Inc. are of similar size ($253.8M and $251.0M). CAMP4 Therapeutics Corporation has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. CAMP4 Therapeutics Corporation grew revenue faster over the last twelve months: 52.0% against −307.3%. Q32 Bio Inc. has the higher net margin (808.0% vs −2,276.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Q32 Bio Inc. leads on 11 and CAMP4 Therapeutics Corporation on 1.
Valuation
Profitability
| Metric | CAMP | QTTB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (1,001.05%) | 725.53% | 0.00% |
| Net margin | (2,276.33%) | 808.04% | 0.00% |
| Free cash flow margin | — | 280.89% | 0.00% |
| Return on equity | (146.12%) | 23.96% | (51.58%) |
| Return on assets | (109.89%) | 18.17% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack